Edgestream Partners’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.8M | Buy |
+11,847
| New | +$1.8M | 0.05% | 548 |
|
|
2025
Q1 | – | Sell |
-12,880
| Closed | -$2.38M | – | 880 |
|
|
2024
Q4 | $2.38M | Buy |
+12,880
| New | +$2.38M | 0.1% | 360 |
|
|
2024
Q3 | – | Sell |
-16,725
| Closed | -$3.46M | – | 877 |
|
|
2024
Q2 | $3.46M | Buy |
+16,725
| New | +$3.46M | 0.17% | 207 |
|
|
2022
Q1 | – | Sell |
-9,672
| Closed | -$3.64M | – | 549 |
|
|
2021
Q4 | $3.64M | Buy |
9,672
+5,524
| +133% | +$2.08M | 0.23% | 140 |
|
|
2021
Q3 | $1.71M | Buy |
+4,148
| New | +$1.71M | 0.11% | 258 |
|